Originally published In Press as doi:10.1074/jbc.M107997200 on February 11, 2002
J. Biol. Chem., Vol. 277, Issue 16, 13883-13888, April 19, 2002
Secretion of Antithrombin Is Converted from Nonpolarized to
Apical by Exchanging Its Amino Terminus for That of Apically Secreted
Family Members*
Lotte K.
Vogel
§,
Sia
Sahkri
,
Hans
Sjöström
,
Ove
Norén
, and
Martin
Spiess¶
From the
Department of Medical Biochemistry and
Genetics, Biochemistry Laboratory C, University of Copenhagen, The
Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark and the
¶ Biozentrum, University of Basel, CH-4056
Basel, Switzerland
Received for publication, August 20, 2001, and in revised form, February 6, 2002
 |
ABSTRACT |
The three members of the serpin family,
corticosteroid binding globulin,
1-antitrypsin, and C1 inhibitor are
secreted apically from Madin-Darby canine kidney (MDCK) cells, whereas
two homologous family members, antithrombin and plasminogen activator
inhibitor-1, are secreted in a nonpolarized fashion. cDNAs coding
for chimeras composed of complementary portions of an apically targeted
serpin and a nonsorted serpin were generated, expressed in MDCK cells, and the ratio between apical and basolateral secretion was analyzed. These experiments identified an amino-terminal sequence of
corticosteroid binding globulin (residues 1-19) that is sufficient to
direct a chimera with antithrombin mainly to the apical side. A
deletion/mutagenesis analysis showed that no individual amino acid is
absolutely required for the apical targeting ability of amino acids
1-30 of corticosteroid binding globulin. The corresponding
amino-terminal sequences of
1-antitrypsin and C1 inhibitor were
also sufficient to confer apical sorting. Based on our results we
suggest that the apical targeting ability is encoded in the
conformation of the protein.
 |
INTRODUCTION |
In epithelial cells, plasma membrane and secretory proteins are
sorted in a polarized manner either to the apical or the basolateral surface. Sorting signals specifying basolateral sorting have been identified in the cytoplasmic domains of many membrane proteins (1, 2).
Most of them are characterized either by essential tyrosine (3) or
dileucine motifs (4). There is evidence that basolateral sorting of the
receptors for transferrin and low density lipoproteins is mediated by
AP-1 clathrin adaptors with an epithelia-specific isoform of subunit
µ1 (µ1B; Ref. 5). Much less is known about the signals and
mechanisms of apical sorting. Apical signals appear to be localized to
the noncytosolic segments of membrane proteins, since truncation
mutants lacking the cytosolic and transmembrane portions were generally
found to retain apical polarity (6-9). Recently, a role of the
transmembrane domains in apical sorting has been demonstrated for
several proteins (10-13). Also motifs in the cytoplasmic tails of
rhodopsin (14) and the Na+-dependent bile acid
transporter (15, 16) have been shown to mediate apical sorting. With
respect to polarized secretion of secretory proteins, it has been
shown, for example, that Madin-Darby canine kidney
(MDCK)1 cells secrete
gp80/clusterin (17), erythropoietin (18), and corticosteroid binding
globulin (CBG) (19) mainly from the apical side, whereas a range of
proteins, including growth hormone, lysozyme, prochymosin, the
immunoglobulin
chain (20), cystatin C (6), and uteroglobin (21),
are secreted equally from both plasma membrane domains. It was shown
that N-linked glycans can act as apical targeting signals
for secretory proteins, based on the observation that growth hormone,
normally secreted in a nonpolarized manner from MDCK cells, is secreted
mainly from the apical side after insertion of one or two
N-linked glycosylation sites (22). In addition,
erythropoietin, which is normally secreted at the apical side of MDCK
cells, is secreted in a nonpolarized manner after mutation of two
distinct N-linked glycosylation consensus sequences (18).
However, N-linked glycosylation is not the only apical
targeting signal for secretory proteins, since mutagenesis of the six
N-glycosylation sites of CBG, individually or together, did
not affect its apical secretion from MDCK cells (23). Other examples
where mutation of the only N-glycosylation site did not affect the polarity of secretion are the Hepatitis B surface antigen (24) and a soluble form of the p75 neurotrophin receptor (25). In
addition, chromogranin A is not N-glycosylated but
nevertheless is secreted mainly from the apical side of MDCK cells
(26). Thus, there seem to be at least two mechanisms of apical sorting of secretory proteins, either dependent or independent of
N-glycans.
To characterize N-glycan-independent apical sorting, we
studied members of the serpin family as model proteins. Some of them, including CBG (19)
1-antitrypsin (
1) and C1 inhibitor (C1), were
found to be secreted apically from MDCK cells, whereas other members,
including antithrombin (AT) and plasminogen activator inhibitor-1
(PAI-1), are secreted in a nonsorted manner (27). The structural
similarity allowed the construction of chimeras to identify the
sequence requirements for apical sorting. In the present study we have
shown that amino-terminal segments of the three serpins, CBG,
1, and
C1, are sufficient to direct AT to the apical side of MDCK cells. A
combined deletion and mutagenesis analysis showed that no individual
amino acid is essential for the ability of residues 1-30 of CBG to
direct AT mainly apically from MDCK cells.
 |
EXPERIMANTAL PROCEDURES |
Cell Culture--
MDCK cells (strain II), a kind gift from K. Mostov (University of California), were maintained and transfected as
described previously (6). COS-1 cells were grown in modified minimal essential medium supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 units/ml penicillin, and
100 µg/ml streptomycin. COS-1 cells were transfected using
FuGENETM (Roche Molecular Biochemicals, Mannheim, Germany)
according to the manufacturer's instructions. For sorting experiments,
106 cells per well were seeded onto Transwell filters
(Costar Europe Ltd., Badhoevedorp, The Nederlands; pore size, 0.4 µm;
diameter, 24.5 mm) allowing separate access to the apical and
basolateral membranes. Filters were used for experiments 1-2 days
after confluence as judged by assessing the tightness of the monolayer
(28). Under these conditions the monolayers have a transepithelial
resistance of ~450 ohms cm2 measured by a
Millicell®-ERS voltohmmeter (Millipore Continental Water Systems,
Bedford, MA).
DNA Constructs--
The pRc/CMV vector was used for recombinant
expression of all constructs. cDNAs encoding human CBG (29), rabbit
AT (30), human
1 (31), and human C1 (32) were used. Chimeras were generated using standard DNA techniques. The rat enkephalin signal sequence (33) was used in the following constructs:
AT36-419,
AT41-419,
CBG6-30AT, and
CBG12-30AT.
CBG6-30AT and
AT41-419 were constructed
so they contain the same 3'- and 5'-untranslated regions, the same
cleavable signal peptide, and apart from the amino-terminal 25 amino
acids, the same coding sequence. All cDNA constructs were verified
by sequencing. Numbers in construct names refer to amino acid number of
the mature protein after signal peptidase cleavage.
Metabolic Labeling of Cells and
Immunoprecipitation--
Confluent MDCK cells seeded on filters were
preincubated for 30 min in methionine-free medium and thereafter
pulse-labeled with 500 µCi/ml of [35S]methionine
in methionine-free minimal essential medium added to the
basolateral chamber. After a 20-min pulse, the medium was removed, and
1 ml of chase medium was added to both the apical and basolateral
chambers. After a 4-h chase, the apical and basolateral media were
collected and used for immunoprecipitation. Immunoprecipitation was
performed as described previously (34), and the
immunoprecipitated proteins were analyzed using NuPAGE gels (Novex, San
Diego, CA). A rabbit anti-human CBG-antiserum (35) was used for
immunoprecipitation of wild-type CBG and AT·CBG20-383.
Affinity-purified sheep anti-rabbit antithrombin IgG (a kind gift from
Dr. Sheffield and Dr. Blajchman, McMaster University, Ontario, Canada)
was used for immunoprecipitation of rabbit antithrombin and all
chimeras except AT·CBG20-383.
To ensure that the immunoprecipitations were quantitative, each sample
was subjected to a series of 2-fold dilutions. An equal volume of each
dilution was immunoprecipitated separately with a fixed amount of
antibody, analyzed on NuPAGE gels, and quantified using a
phosphorimager. Linearity of the signal confirmed that immunoprecipitation was quantitative (as shown previously (23)).
 |
RESULTS |
Secretion Is Apical for CBG, but Nonpolarized for AT--
Three
members of the serpin family (CBG,
1, C1) are secreted apically from
MDCK cells, whereas AT and PAI-1 are secreted in a nonpolarized manner
(19, 27). To identify the apical targeting determinant we generated
chimeras between an apically targeted member of the family and a
nonsorted member. We first chose CBG and AT, which have 33% identity
and 45% similarity, and for which good antibodies were available.
It has previously been observed that stable transfected clonal cell
lines expressing CBG showed some variation in the efficiency of apical
secretion in the range of 69-83% apical (19). To eliminate clonal
variation, transfected G418-resistant cells expressing CBG
(approximately 200 independent clones) were pooled. The cells were
grown to confluence on filters, pulse-labeled for 20 min with
[35S]methionine, and chased for 4 h. The apical and
basolateral media were collected, subjected to immunoprecipitation, and
analyzed by NuPAGE-gel electrophoresis. As shown in Fig.
1, wild-type CBG was secreted in a
polarized manner from a pool of MDCK clones with an apical/basolateral
ratio of 78/22. Wild-type CBG (and some of the chimeras, see below)
runs as multiple bands due to partial utilization of three of its six
N-glycosylation sites (36). Essentially the same results
were obtained in three independent transfections. This is very similar
to what had been obtained for individually isolated clones of MDCK
cells expressing the protein (19, 23). Recombinantly expressed AT was
secreted from a pool of clones at an apical/basolateral ratio of 44/56 (Fig. 1), which is similar to the result obtained when individual isolated clones were analyzed (27). On this basis we decided to analyze
pools of clones instead of individual clones throughout this study.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 1.
Apical targeting correlates with the presence
of the amino-terminal end of CBG. Pools of MDCK cells expressing
CBG, AT, CBG1-43AT, CBG1-34AT,
CBG1-30AT, or CBG1-19AT were seeded on
filters. Tight filter-grown cells were labeled for 20 min with
[35S]methionine and chased for 4 h. Apical
(Ap) and basolateral (Ba) media were collected
separately and individually immunoprecipitated in various dilutions
(×2 and ×4) with a fixed amount of antibodies. The immunoprecipitates
were analyzed on NuPAGE gels (right panel). Only when the
dilution resulted in a corresponding reduction in the signal (as in the
experiments shown) was it assumed that the immunoprecipitation was
quantitative, and the result was quantitated using a phosphorimager
(left panel). Bars represent mean ± S.D.
for 5-10 experiments.
|
|
The Amino-terminal Sequence of CBG Is Sufficient for Apical
Targeting--
Initially a series of eight chimeras was generated
between CBG and AT. The first chimera consisted of the amino terminus
of CBG, including the signal peptide and amino acids 1-43 of the mature protein fused in-frame with the complementary carboxyl terminus
of AT (amino acids 80-419) Fig. 2. This
construct was named CBG1-43AT. The reverse construct
containing the signal peptide and the amino-terminal part of AT up to
amino acid 79 (Fig. 2) followed by the complementary carboxyl terminus
portion of CBG was correspondingly named AT·CBG44-383.
CBG1-43AT and AT·CBG44-383 thus are each
others inverted chimera. We also constructed CBG1-113AT,
AT·CBG114-383, CBG1-215AT, AT·CBG216-383, CBG1-297AT, and
AT·CBG298-383, a total of four pairs of inverted
chimeras.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Mutants constructed to characterize apical
sorting information on CBG and their distribution between the apical
and basolateral media after expression in MDCK cells. Gray
boxes represent CBG, and white boxes represent AT. The
arrows indicate fusion points used in the constructs
below.
|
|
As a first test of expression and secretion, the eight chimeras and
wild-type CBG and AT were transiently transfected into COS-1 cells. All
constructs were expressed. However, after a 20-min pulse and a 4-h
chase, only wild-type AT, wild-type CBG, and the chimera
CBG1-43AT were efficiently secreted (data not shown), indicating that the other seven chimeras were not efficiently folded in
the endoplasmic reticulum. We did not study these seven chimeras
further. All constructs described in this study were tested for
expression and secretion efficiency in COS-1 cells and/or MDCK cells in
this manner. Only constructs with expression and secretion efficiency
between the two wild-type proteins were analyzed further unless
otherwise stated.
When expressed in MDCK cells and analyzed on filters as described
above, CBG1-43AT was secreted predominantly from the apical surface, with an apical/basolateral ratio of 79/21 (Fig. 1). The
amino-terminal 43 amino acids of CBG are thus sufficient to confer
apical targeting to the chimeric protein. To further define the peptide
sufficient for apical targeting, we constructed three new chimeras,
CBG1-34AT, CBG1-30AT, and
CBG1-19AT (Fig. 2). In MDCK cells, all three chimeric
proteins were secreted mainly from the apical side (Fig. 1) with
apical/basolateral ratios of 81/19, 85/15, and 75/25 for
CBG1-34AT, CBG1-30AT, and
CBG1-19AT, respectively. These experiments narrowed the
sequence sufficient to confer apical targeting down to residues 1-19
of CBG.
The Apical Targeting of Chimeras Is Not Due to Truncation of the
Amino Terminus of AT--
The chimeric constructs described so far are
all shorter at the amino terminus than AT, which has an amino-terminal
extension compared with CBG. To investigate whether the apical
secretion of the chimeric molecules is due to the peptide sequence
transferred from CBG or to the truncation of the molecule, the 35 amino-terminal residues of AT were deleted by fusing a cleavable signal
peptide in front of amino acids 36-419 of AT. The resulting construct was named
AT36-419 (Fig. 2). In a second version of
this construct,
AT41-419, an additional 5 amino acids
were deleted at the amino terminus (Fig. 2). Upon expression in
filter-grown MDCK cells
AT36-419 was secreted with an
apical/basolateral ratio of 50/50 and
AT41-419 with an
apical/basolateral ratio of 52/48 (data not shown). As a control, the
secretion of gp80/clusterin, an endogenous apical secretory protein,
was also examined and found to be secreted mainly apically from the
cells expressing
AT36-419 and
AT41-419
(data not shown). These cells thus have not lost their ability to
target proteins to the apical side. Truncation of the amino terminus of
AT alone is therefore not enough to induce apical targeting of the molecule.
The Amino-terminal Sequences of
1 and C1 Are Also Sufficient for
Apical Targeting of Chimeras with AT--
Like CBG, the serpins
1
and C1 are also secreted mainly apically from MDCK cells (27). An
alignment of the amino-terminal sequences of these three serpins and
the two nonsorted serpins, AT and PAI-1 (Fig.
3A), shows a big diversity in
length and sequence, also when only the apically secreted serpins are
compared. To determine whether the amino terminus of
1 or C1 can,
like that of CBG, direct a chimera with AT into the apical pathway, we
constructed the two chimeras,
11-39AT and
C11-132AT, consisting of amino acids 1-39 of
1 and
1-132 of C1, respectively, fused to their corresponding carboxyl
terminus of AT.
11-39AT was fused at the same point as
CBG1-30AT, whereas the fusion point of
C11-132AT was one amino acid further toward the amino
terminus. Both constructs were secreted mainly to the apical side with
an apical/basolateral ratio of 71/29 for
11-39AT and of
75/25 for C11-132AT (Fig. 3B). The
amino-terminal portions of
1 and C1 are thus equally capable of
conferring apical targeting to AT as that of CBG.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 3.
The amino termini of
1 and C1 are able to confer apical targeting to
AT. A, alignment of the amino-terminal sequences of the
apical serpins C1, 1, and CBG and of the nonpolarized serpins AT and
PAI-1. The 19 residues of CBG sufficient for apical sorting are
underlined. The fusion points for 11-39AT
and C11-132AT are indicated by arrows.
B, filter-grown cells expressing 11-39AT or
C11-132AT were analyzed as described in the legend
to Fig. 1. Bars represent mean ± S.D. for nine
experiments.
|
|
Apical Targeting by Residues 1-30 of CBG Does Not Depend on Any
Individual Amino Acid--
We investigated the significance of
residues 1-30 of CBG for apical targeting more in detail. To test
whether amino acids 1-5 of CBG are important, we made a construct
containing a cleavable signal peptide and amino acids 6-30 of CBG
followed by the complementary carboxyl-terminal end of AT
(
CBG6-30AT) (Fig. 2).
CBG6-30AT is
secreted from MDCK cells at an apical/basolateral ratio of 67/33 Fig.
4. This shows that amino acids 1-5 of
CBG are not necessary for apical targeting. Deletion of an additional 6 residues (
CBG12-30AT) resulted in a chimeric protein
that was hardly secreted (not shown), suggesting that residues 6-11
are important for efficient folding of the protein.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Amino acids 1-5 are unimportant for apical
targeting. A pool of MDCK cells expressing
CBG6-30AT or AT·CBG20-383 was seeded on
filters. The experiments were performed as described in legend to Fig.
1. Bars represent mean ± S.D. for eight
experiments.
|
|
To investigate the importance of each individual amino acid in the
sequence 6-30 of CBG for the apical targeting ability, we mutated
individual amino acids in the CBG1-30AT construct to the
amino acid present at the corresponding position in AT according to our
alignment shown in Fig. 3. When comparing the sequence 6-30 of CBG and
the corresponding sequence of AT, there are 7 positions where the two
proteins have identical amino acids. Thus a total of 18 mutants were
constructed. Upon expression in MDCK cells all but one of the mutant
proteins (CBG1-30AT H14V) were efficiently secreted into
the media and all of them with essentially the same polarity as
CBG1-30AT (Fig. 5). The
mutation H14V was instead constructed in the context of
CBG1-19AT, and the resulting protein
(CBG1-19AT H14V) was efficiently expressed and secreted
predominantly into the apical medium essentially like
CBG1-19AT. These results show that no single
amino acid is absolutely required for apical targeting of the amino acids 1-30 of CBG.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 5.
Apical targeting by residues 1-30 of CBG
does not depend on any individual amino acid. A,
residues 1-30 of CBG and the corresponding sequence of AT are shown.
AT36-419 (nonpolarized secreted) and
CBG1-30AT (mainly apically secreted) differs only in the
residues 1-30 identical to the differences between the sequences of
CBG and AT shown. Compared with CBG1-30AT,
CBG6-30AT has a deletion of the NH2-terminal 5 residues shown by , but is still secreted mainly apically. In the
context of CBG1-30AT, residues that are different in the
corresponding sequence of AT were individually mutated to the amino
acid present at the corresponding position in AT (e.g.
CBG1-30AT S11N). An exception is the mutation H14V
(indicated by an asterisk), which was constructed in
the context of CBG1-19AT. For each of the 18 mutants
filter-grown cells were seeded on filters, and the experiments were
performed as described in legend to Fig. 1 and analyzed on NuPAGE gels
shown (B). The gels were quantitated using a phosphorimager,
and bars representing mean ± S.D. of four to nine
determinations are shown (A).
|
|
Residues 20-383 of CBG Are Also Sufficient for Apical
Targeting--
Our results show that the amino-terminal 19 residues of
CBG are sufficient for apical targeting of a chimera with AT. To test whether the amino-terminal sequence is the only determinant of polarity, AT·CBG20-383, i.e. the inverted
chimera of CBG1-19AT, was constructed.
AT·CBG20-383 was secreted apically from MDCK
cells at an apical/basolateral ratio of 70/30 (Fig. 4). This result
shows that the carboxyl terminus of CBG contains additional determinants conferring apical targeting to a chimeric protein. Similarly, AT·CBG31-383, the inverted chimera of
CBG1-30AT, was secreted mainly to the apical side of MDCK
cells, but at a lower rate than wild-type CBG (data not shown).
 |
DISCUSSION |
Polarized secretion might be generated by signal-mediated delivery
to one surface and a default pathway to the other. Alternatively, delivery to both destinations may be signal-mediated. It was recently shown that the apical sorting machinery in RPE-J cells could be saturated by overexpression (37), strongly suggesting that apical secretion is signal-mediated at least in this cell line.
In the present study, we analyzed the sorting of members of the serpin
family that are either targeted predominantly to the apical side of
MDCK monolayers (CBG,
1, and C1) or secreted in a nonpolarized
manner (AT and PAI-1). Analyzing chimeras between CBG and AT, we found
that a short peptide derived from the amino-terminal end of CBG is able
to confer apical targeting to the recombinant proteins. Apical
secretion was not due to truncation of the 35-amino acid amino-terminal
extension present in AT and lacking in CBG, since its deletion did not
result in apical targeting. The amino-terminal extension of AT thus
does not carry basolateral sorting information or hide apical sorting information.
Amino acids 1-19 or 6-30 of CBG are able to confer apical targeting,
suggesting that the determinant is contained within residues 6-19 of
CBG. The amino-terminal sequences of
1 (residues 1-39) and of C1
(residues 1-132) are also able to confer apical targeting to the
corresponding AT fusion proteins. Comparison of these sequences reveals
hardly any conservation on the amino acid level. There is only one
conserved position, a hydrophobic residue at the position corresponding
to residue 17 of CBG. However, the two nonsorted serpins also have a
hydrophobic amino acid at this position (Leu in AT and Val in PAI-1).
The presence of a nonpolar side chain at this position is thus likely
to be preferred in the serpin fold, but unlikely to be crucial for
apical targeting. We are thus unable to identify a peptide motif
putatively responsible for apical targeting. A combined deletion and
mutagenesis analysis showed that no single amino acid in residues 1-30
of CBG is absolutely required for apical targeting. However, as both
residues 1-19 and 20-383 of CBG are able to confer apical targeting
ability, it is formally possible, albeit not very likely, that residues 1-30 of CBG contain two apical determinants, and consequently the
mutagenesis analysis would miss identifying them. However, the lack of
conservation between the amino-terminals of CBG,
1, and C1 suggest
that apical targeting is not mediated by a conserved linear amino acid sequence.
This situation is reminiscent of that recently described for the apical
sorting of the
-subunit of the gastric H,K-ATPase. Analysis of
chimeras between the
-subunits of the apical H,K-ATPase and of the
homologous basolateral Na,K-ATPase identified the predicted fourth
transmembrane domain (TM4) of the H,K-ATPase as sufficient for apical
sorting in LLC-PK1 cells (13). Furthermore, the two flanking regions of
TM4 were also able to redirect the protein to the apical side of the
cells, whereas either one of the flanking sequences alone was not (13).
The flanking sequences were proposed to induce a conformational change
in TM4 of the Na,K-ATPase, mimicking the conformation of TM4 of the
H,K-ATPase. Alternatively, TM4 or the flanking sequences of the
H,K-ATPase may impose certain conformations on other parts of the
protein, which could then be recognized by components of the apical
sorting machinery. In a similar manner the serpins analyzed here may
carry a conformation-dependent apical sorting signal either
in the amino terminus or elsewhere in the protein.
In the present study we have shown that not only amino acids 1-19 of
CBG carry apical targeting information, but also amino acids 20-383.
Redundant signals thus appear to ensure correct cellular localization
of CBG, comparable with the low density lipoprotein receptor and
CD1d, which was shown to have multiple basolateral sorting signals (38,
39). Also influenza virus neuraminidase, a transmembrane protein,
possesses two apical determinants: one in the ectodomain (10) and the
other in the transmembrane domain (40).
Residues 1-30 of CBG contain one consensus sequence for
N-glycosylation at Asn9, but mutation of
this site in the context of wild-type CBG (23) or in the context of
CBG1-30AT (CBG1-30AT N9A or
CBG1-30AT S11N) did not disturb apical targeting of the
recombinant product. As CBG may have redundant apical targeting
information, even within residues 1-30, N-glycosylation
alone is not the apical determinant, but it cannot be excluded that
N-glycosylation serves as an apical targeting determinant in
addition to a determinant of a different nature. CBG does not carry
O-linked glycosylation, which had been suggested to act as
an apical determinant for the neurotrophin receptor (25).
It cannot be formally excluded that the effect of the amino-terminal
sequence of CBG on sorting is not due to the introduction of an apical
sorting determinant, but is instead attributable to the disruption of a
weak basolateral localization signal in AT. However, we consider this
unlikely, since a number of exogenous proteins from diverse sources
lacking polarized sorting are secreted in a nonpolarized manner from
MDCK cells (6, 20, 21).
We envision that the apical targeting of serpins is a receptor-mediated
process and that the receptors in turn have a regulated intracellular
traffic. It has been suggested that detergent-resistant membranes
function as apical targeting platforms (41). In addition it was
recently shown that the apically targeted, secretory protein thyroglobulin associates with detergent-resistant membranes during transport to the cell membrane (42). However, a correlation between
apical targeting and association to the detergent-resistant membrane
could not be observed when wild-type serpins and chimeras of serpins
were investigated.2 It is
thus unlikely that detergent-resistant membranes are involved in the
apical transport of serpins.
In this paper we have shown that the exchange of a short
NH2-terminal peptide of the nonsorted serpin AT by the
nonconserved NH2-terminal peptides derived from three
apical members of the serpin family is able to confer apical targeting.
On this basis we suggest that polarized sorting of the apically
secreted serpins does not depend on a strictly conserved linear
sequence but may depend on the protein's conformation.
 |
ACKNOWLEDGEMENTS |
We give special thanks to the people in the
Spiess laboratory and the Norén/Sjöström laboratory
for the nice and friendly environment. We are grateful to Drs.
W. P. Sheffield, R. G. Crystal, S. C. Bock, and C. Koch-Brandt for cDNAs and antibodies and Dr. G. L. Hammond for
many helpful suggestions and for CBG cDNA and antibodies. Also we
thank Dr. C. Mitchelmore for careful reading of the manuscript and Dr.
P. Harris for helpful discussion.
 |
FOOTNOTES |
*
This work was supported by the Desirée and Niels Ydes
Foundation, The Novo Nordisc Foundation, the Danish Cancer Society, the
Danish Medical Research Council, The Lundbeck Foundation, and the Swiss
National Science Foundation (Grant 3100-061579.00 (to M. S.)). The
project was part of a program under the Biomembrane Research Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Medical
Biochemistry and Genetics, Biochemistry Laboratory C, University of
Copenhagen, The Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen N,
Denmark. Tel.: 45-35327789; Fax: 45-35367980; E-mail:
Vogel@imbg.ku.dk.
Published, JBC Papers in Press, February 11, 2002, DOI 10.1074/jbc.M107997200
2
J. E. Larsen, H. Sjöström, O. Norén, and L. K. Vogel, submitted for publication.
 |
ABBREVIATIONS |
The abbreviations used are:
MDCK, Madin-Darby
canine kidney;
AT, antithrombin;
1,
1-antitrypsin;
CBG, corticosteroid binding globulin;
C1, C1 inhibitor;
PAI-1, plasminogen
activator inhibitor-1.
 |
REFERENCES |
| 1.
|
Trowbridge, I. S.,
Collawn, J. F.,
and Hopkins, C. R.
(1993)
Annu. Rev. Cell Biol.
9,
129-161[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Matter, K.,
and Mellman, I.
(1994)
Curr. Opin. Cell Biol.
6,
545-554[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Marks, M. S.,
Ohno, H.,
Kirchhousen, T.,
and Bonifacino, S. J.
(1997)
Trends Cell Biol.
7,
124-128[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Sandoval, I. V.,
and Bakke, O.
(1994)
Trends Cell Biol.
4,
292-297[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Folsch, H.,
Ohno, H.,
Bonifacino, J. S.,
and Mellman, I.
(1999)
Cell
99,
189-198[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Vogel, L. K.,
Spiess, M.,
Sjostrom, H.,
and Noren, O.
(1992)
J. Biol. Chem.
267,
2794-2797[Abstract/Free Full Text]
|
| 7.
|
Vogel, L. K.,
Noren, O.,
and Sjostrom, H.
(1992)
FEBS Lett.
308,
14-17[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Corbeil, D.,
Boileau, G.,
Lemay, G.,
and Crine, P.
(1992)
J. Biol. Chem.
267,
2798-2801[Abstract/Free Full Text]
|
| 9.
|
Weisz, O. A.,
Machamer, C. E.,
and Hubbard, A. L.
(1992)
J. Biol. Chem.
267,
22282-22288[Abstract/Free Full Text]
|
| 10.
|
Kundu, A.,
and Nayak, D. P.
(1994)
J. Virol.
68,
1812-1818[Abstract/Free Full Text]
|
| 11.
|
Scheiffele, P.,
Roth, M. G.,
and Simons, K.
(1997)
EMBO J.
16,
5501-5508[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Lin, S.,
Naim, H. Y.,
Rodriguez, A. C.,
and Roth, M. G.
(1998)
J. Cell Biol.
142,
51-57[Abstract/Free Full Text]
|
| 13.
|
Dunbar, L. A.,
Aronson, P.,
and Caplan, M. J.
(2000)
J. Cell Biol.
148,
769-778[Abstract/Free Full Text]
|
| 14.
|
Chuang, J. Z.,
and Sung, C. H.
(1998)
J. Cell Biol.
142,
1245-1256[Abstract/Free Full Text]
|
| 15.
|
Sun, A. Q.,
Ananthanarayanan, M.,
Soroka, C. J.,
Thevananther, S.,
Shneider, B. L.,
and Suchy, F. J.
(1998)
Am. J. Physiol.
275,
G1045-G1055[Medline]
[Order article via Infotrieve]
|
| 16.
|
Sun, A. Q.,
Arrese, M. A.,
Zeng, L.,
Swaby, I.,
Zhou, M. M.,
and Suchy, F. J.
(2001)
J. Biol. Chem.
276,
6825-6833[Abstract/Free Full Text]
|
| 17.
|
Urban, J.,
Parczyk, K.,
Leutz, A.,
Kayne, M.,
and Kondor-Koch, C.
(1987)
J. Cell Biol.
105,
2735-2743[Abstract/Free Full Text]
|
| 18.
|
Kitagawa, Y.,
Sano, Y.,
Ueda, M.,
Higashio, K.,
Narita, H.,
Okano, M.,
Matsumoto, S.-I.,
and Sasaki, R.
(1994)
Exp. Cell Res.
213,
449-457[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Musto, N. A.
(1993)
Exp. Cell Res.
209,
271-276[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Gottlieb, T. A.,
Beaudry, G.,
Rizzolo, L.,
Colman, A.,
Rindler, M.,
Adesnik, M.,
and Sabatini, D. D.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
2100-2104[Abstract/Free Full Text]
|
| 21.
|
Vogel, L. K.,
Suske, G.,
Beato, M.,
Noren, O.,
and Sjostrom, H.
(1993)
FEBS Lett.
330,
293-296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Scheiffele, P.,
Peranen, J.,
and Simons, K.
(1995)
Nature
378,
96-98[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Larsen, J. E.,
Avvakumov, G. V.,
Hammond, G. L.,
and Vogel, L. K.
(1999)
FEBS Lett.
451,
19-22[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Marzolo, M. P.,
Bull, P.,
and Gonzalez, A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1834-1839[Abstract/Free Full Text]
|
| 25.
|
Yeaman, C., Le,
Gall, A. H.,
Baldwin, A. N.,
Monlauzeur, L., Le,
Bivic, A.,
and Rodriguez-Boulan, E.
(1997)
J. Cell Biol.
139,
929-940[Abstract/Free Full Text]
|
| 26.
|
Kuhn, U.,
Cohn, D. V.,
and Gorr, S. U.
(2000)
Biochem. Biophys. Res. Commun.
270,
631-636[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Vogel, L. K.,
and Larsen, J. E.
(2000)
FEBS Lett.
473,
297-302[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Wessels, H. P.,
Geffen, I.,
and Spiess, M.
(1989)
J. Biol. Chem.
264,
17-20[Abstract/Free Full Text]
|
| 29.
|
Hammond, G. L.,
Smith, C. L.,
Goping, I. S.,
Underhill, D. A.,
Harley, M. J.,
Reventos, J.,
Musto, N. A.,
Gunsalus, G. L.,
and Bardin, C. W.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
5153-5157[Abstract/Free Full Text]
|
| 30.
|
Sheffield, W. P.,
Brothers, A. B.,
Wells, M. J.,
Hatton, M. W.,
Clarke, B. J.,
and Blajchman, M. A.
(1992)
Blood
79,
2330-2339[Abstract/Free Full Text]
|
| 31.
|
Gilardi, P.,
Courtney, M.,
Pavirani, A.,
and Perricaudet, M.
(1990)
FEBS Lett.
267,
60-62[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Bock, S. C.,
Skriver, K.,
Nielsen, E.,
Thogersen, H. C.,
Wiman, B.,
Donaldson, V. H.,
Eddy, R. L.,
Marrinan, J.,
Radziejewska, E.,
and Huber, R.
(1986)
Biochemistry
25,
4292-4301[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Cescato, R.,
Dumermuth, E.,
Spiess, M.,
and Paganetti, P. A.
(2000)
J. Neurochem.
74,
1131-1139[Medline]
[Order article via Infotrieve]
|
| 34.
|
Vogel, L. K.,
Noren, O.,
and Sjostrom, H.
(1995)
J. Biol. Chem.
270,
22933-22938[Abstract/Free Full Text]
|
| 35.
|
Robinson, P. A.,
and Hammond, G. L.
(1985)
J. Endocrinol.
104,
269-277[Abstract/Free Full Text]
|
| 36.
|
Avvakumov, G. V.
(1995)
J. Steroid Biochem. Mol. Biol.
53,
515-522[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Marmorstein, A. D.,
Csaky, K. G.,
Baffi, J.,
Lam, L.,
Rahaal, F.,
and Rodriguez-Boulan, E.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
3248-3253[Abstract/Free Full Text]
|
| 38.
|
Matter, K.,
Hunziker, W.,
and Mellman, I.
(1992)
Cell
71,
741-753[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Rodionov, D. G.,
Nordeng, T. W.,
Kongsvik, T. L.,
and Bakke, O.
(2000)
J. Biol. Chem.
275,
8279-8282[Abstract/Free Full Text]
|
| 40.
|
Kundu, A.,
Avalos, R. T.,
Sanderson, C. M.,
and Nayak, D. P.
(1996)
J. Virol.
70,
6508-6515[Abstract]
|
| 41.
|
Simons, K.,
and Ikonen, E.
(1997)
Nature
387,
569-572[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Martin-Belmonte, F.,
Alonso, M. A.,
Zhang, X.,
and Arvan, P.
(2000)
J. Biol. Chem.
275,
41074-41081[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Carmosino, I. Gimenez, M. Caplan, and B. Forbush
Exon Loss Accounts for Differential Sorting of Na-K-Cl Cotransporters in Polarized Epithelial Cells
Mol. Biol. Cell,
October 1, 2008;
19(10):
4341 - 4351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Castelletti, G. Fracasso, M. Alfalah, S. Cingarlini, M. Colombatti, and H. Y. Naim
Apical Transport and Folding of Prostate-specific Membrane Antigen Occurs Independent of Glycan Processing
J. Biol. Chem.,
February 10, 2006;
281(6):
3505 - 3512.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.